Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Aphelion Capital is a healthcare venture capital firm founded in 2005 and headquartered in the United States. The firm specializes in early and mid-stage investments in medical device and digital health companies. Aphelion Capital aims to improve patient outcomes while maintaining or lowering costs to the healthcare system. Over the years, the firm has established a reputation for its commitment to supporting innovative healthcare solutions.
With a diverse portfolio that includes both active companies and those that have gone public, Aphelion Capital has successfully navigated the complexities of the healthcare sector. The firm collaborates closely with entrepreneurs, providing them with the necessary resources and support to achieve long-term success. Aphelion Capital's focus on financial discipline ensures that its portfolio companies are well-positioned for sustainable growth.
Aphelion Capital invests in medical technologies and services that offer innovative approaches to healthcare delivery. The firm targets companies dedicated to improving clinical outcomes, emphasizing financial discipline in their operations. Investment stages range from pre-seed to Series C, allowing Aphelion to engage with startups at various points in their development.
The firm primarily focuses on the healthcare, biotech, and digital health sectors, seeking out opportunities that align with its mission to enhance patient care. Aphelion Capital values collaboration with entrepreneurs, providing them with essential support and resources to navigate the challenges of the healthcare landscape. This collaborative approach is integral to the firm's investment strategy, ensuring that portfolio companies are equipped for long-term success.
Aphelion Capital has a diverse portfolio that includes several notable companies, many of which have been acquired by major firms. Key exits include:
In addition to these exits, Aphelion Capital continues to support active companies in its portfolio, contributing to advancements in healthcare technology and services.
Ned Scheetz - Managing Partner. Ned has extensive experience in venture capital and healthcare investments, having led numerous successful deals in the medical technology sector.
Chris Baker, MD - Clinical Partner. Dr. Baker brings clinical expertise to the firm, enhancing its ability to evaluate healthcare innovations effectively.
Jake Martellaro - Principal. Jake focuses on sourcing and evaluating investment opportunities in the healthcare space.
John Kim, MD - Managing Director. Dr. Kim has a strong background in clinical practice and healthcare investments, contributing valuable insights to the firm.
Shifali Singh, PhD - Clinical Associate. Shifali supports the evaluation of medical technologies and services from a clinical perspective.
Katie Belt - Executive Assistant. Katie provides administrative support to the team, ensuring smooth operations.
Bob Mellen - Venture Partner. Bob brings a wealth of experience in venture capital and healthcare investments.
Robert Thomas - Venture Partner. Robert has a strong track record in supporting healthcare startups and guiding them through growth phases.
To pitch Aphelion Capital, founders should send their proposals via email to venturedeals@aphelioncap.com. A well-structured deck that outlines the business model, market opportunity, and team background is essential. Response times may vary, but founders can expect feedback within a few weeks.
In recent months, Aphelion Capital has continued to expand its portfolio, focusing on innovative healthcare solutions. The firm has made several investments in early-stage medical technology companies, reinforcing its commitment to enhancing patient outcomes.
Additionally, Aphelion Capital has been involved in discussions regarding potential partnerships with other venture capital firms to co-invest in promising healthcare startups. This collaborative approach aims to leverage shared expertise and resources to support the growth of portfolio companies.
What investment criteria does Aphelion Capital look for?
Aphelion Capital seeks companies that focus on innovative medical technologies and services aimed at improving clinical outcomes. The firm emphasizes financial discipline and operational efficiency.
How can I pitch to Aphelion Capital?
Founders can pitch their ideas by sending an email to venturedeals@aphelioncap.com. It is advisable to include a detailed deck that outlines the business model, market opportunity, and team background.
What makes Aphelion Capital different from other VCs?
Aphelion Capital's focus on healthcare innovation and its extensive experience in the medical technology sector set it apart. The firm collaborates closely with entrepreneurs, providing tailored support and resources.
What is the geographic scope of Aphelion Capital's investments?
The firm primarily invests in companies based in the United States, focusing on the healthcare, biotech, and digital health sectors.
What is the typical check size for investments?
Aphelion Capital invests across various stages, from pre-seed to Series C, with check sizes varying based on the stage and specific needs of the company.
What kind of post-investment involvement can founders expect?
Aphelion Capital actively engages with its portfolio companies, providing mentorship, operational support, and strategic guidance to help them achieve their goals.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.